Application 209632
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LO-ZUMANDIMINE | DROSPIRENONE; ETHINYL ESTRADIOL | TABLET;ORAL | 3MG;0.02MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50102-240 | Jasmiel | Drospirenone and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-240 | Jasmiel | Drospirenone and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-240 | Jasmiel | Drospirenone and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-240 | Jasmiel | Drospirenone and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-240 | Jasmiel | Drospirenone and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-240 | Jasmiel | Drospirenone and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-240 | Jasmiel | Drospirenone and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 53002-1783 | Jasmiel | Drospirenone and Ethinyl Estradiol | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 59651-029 | Lo-Zumandimine | Drospirenone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 59651-029 | Lo-Zumandimine | Drospirenone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 59651-029 | Lo-Zumandimine | Drospirenone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 59651-029 | Lo-Zumandimine | Drospirenone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 59651-029 | Lo-Zumandimine | Drospirenone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 59651-029 | Lo-Zumandimine | Drospirenone and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |